Journal article
Pfizer-BioNTech and Oxford AstraZeneca COVID-19 vaccine effectiveness and immune response amongst individuals in clinical risk groups
- Abstract:
-
Background: COVID-19 vaccines approved in the UK are highly effective in general population cohorts, however, data on effectiveness amongst individuals with clinical conditions that place them at increased risk of severe disease are limited.
Methods: We used GP electronic health record data, sentinel virology swabbing and antibody testing within a cohort of 712 general practices across England to estimate vaccine antibody response and vaccine effec...
Expand abstract
- Publication status:
- Published
- Peer review status:
- Peer reviewed
Actions
Authors
Bibliographic Details
- Publisher:
- Elsevier Publisher's website
- Journal:
- Journal of Infection Journal website
- Volume:
- 84
- Issue:
- 5
- Pages:
- 675-683
- Publication date:
- 2022-01-02
- Acceptance date:
- 2021-12-29
- DOI:
- EISSN:
-
1532-2742
- ISSN:
-
0163-4453
- Pmid:
-
34990709
Item Description
- Language:
- English
- Keywords:
- Pubs id:
-
1230305
- Local pid:
- pubs:1230305
- Deposit date:
- 2022-07-01
Terms of use
- Copyright holder:
- Elsevier
- Copyright date:
- 2021
- Rights statement:
- © 2021 Published by Elsevier Ltd on behalf of The British Infection Association.
If you are the owner of this record, you can report an update to it here: Report update to this record